This company seems to have been delisted
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
ViewRay
VRAY
$0.04291
Share price
0.00%
Change (1 day)
-99.25%
Change (1 year)
Categories
ViewRay (VRAY) - Total debt
Total debt on the balance sheet as of March 2023 : NZ$0.14 Billion
According to ViewRay's latest financial reports the company's total debt is NZ$0.14 Billion. A company’s total debt is the sum of all current and non-current debts.
ViewRay - Total debt on balance sheet (from 2014 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | NZ$0.13 B | 36.94% |
| 2021-12-31 | NZ$99.37 M | 5.34% |
| 2020-12-31 | NZ$94.34 M | -6.96% |
| 2019-12-31 | NZ$0.10 B | 22.86% |
| 2018-12-31 | NZ$82.53 M | 31.72% |
| 2017-12-31 | NZ$62.66 M | -1.99% |
| 2016-12-31 | NZ$63.93 M | 50.82% |
| 2015-12-31 | NZ$42.39 M | |
| 2014-11-30 | NZ$0 M | 177.21% |
| 2013-11-30 | NZ$0 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | NZ$0.14 B | 0.00% | 🇺🇸 USA |
 | NZ$1.01 B | 595.50% | 🇺🇸 USA |
 | NZ$13.4 M | -90.83% | 🇮🇱 Israel |